News
-
-
PRESS RELEASE
Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance
Medios AG reports 5.8% revenue growth in Q1 2024, reaching €456.2 million. Full-year guidance confirmed, anticipating significant revenue and margin increase. Acquisition of Ceban planned for May 2024 -
-
-
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Medios acquires Dutch market leader in pharmaceutical compounding services
Medios AG acquires Ceban Pharmaceuticals B.V., the Dutch market leader in pharmaceutical compounding services, in a strategic move to expand its business internationally and create a European Specialty Pharma platform